Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Forms Medical Consortium to Advance OSA Technology

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (“OSA”), today announced the official formation of the Vivos Medical Consortium. According to the update, this physician working group, led by Drs. Clete Kushida of Stanford University and Cecilia Wu of the University of Alberta, will collaborate to advance Vivos’ OSA technology capabilities. “Every specialty in medicine deals with the negative impact of obstructive sleep apnea in some way, with the end stage of untreated sleep apnea including diminished quality of life, cardiac and metabolic disease and the potential for premature death,” said Dr. Wu. “Now more than ever, we are seeing the critical importance of optimizing personal health. For decades, the only treatment options for sleep apnea were limited and often invasive, but with the Vivos technology, that has changed dramatically. Our working group of physicians has been impressed by the potential impact of the Vivos technology and its applications, and I am excited to co-lead the Vivos Medical Consortium with Dr. Kushida as we help guide the company’s scientific progress and research endeavors, as well as raise further awareness of the Vivos technology within the medical arena.”

To view the full press release, visit https://ibn.fm/waFkq

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (“OSA”). The Vivos treatment for mild-to-moderate OSA involves a customized oral appliance and protocols called the Vivos System. Vivos believes that its Vivos System oral appliance technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos also sells orthodontic appliances for adults and children. Vivos’ oral appliances have proven effective in over 19,000 patients worldwide by more than 1,250 dentists. Combining technologies and protocols that alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes VivosScore, powered by the SleepImage diagnostic technology for Home Sleep Testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos System. For more information, visit www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Vivos Therapeutics Inc. VVOS | Leave a comment

Infobird Co., Ltd (NASDAQ: IFBD) Signs Service Contract with a Global Leading Retail Brand

  • On August 3, 2021, Infobird signed a service contract with a subsidiary of a global leading retail brand
  • The brand is a Fortune 500 retail and consumer product company and a leader in its sector, with operations in over 80 countries around the world
  • It hopes that through this contract it will capitalize on Infobird’s intelligent quality inspection to improve its customer service system within the Chinese market
  • This move demonstrates Infobird’s commitment to improving what it offers and successfully expanding into the market of retail and consumer product companies

On August 3, 2021, Infobird (NASDAQ: IFBD) announced that it had signed a service contract with a subsidiary of a global leading retail brand (https://ibn.fm/7cclL). This Fortune 500 retail and consumer product company is a leader in its sector and has operations in over 80 countries worldwide. It hopes that, through this contract, it will capitalize on Infobird’s intelligent quality inspection in a bid to significantly improve its customer service system within the Chinese market (https://ibn.fm/Fxs8C). It also hopes to bring users the ultimate consumer experience by creating caring, convenient, and professional customer services.

Infobird is a software-as-a-service (“SaaS”) provider, offering artificial intelligence (“AI”)-powered customer engagement solutions for the Chinese market. Since it was founded in October 2001, this company has always sought to bring value to its clients with solutions to increase revenue, enhance service quality, reduce overheads, and improve customer satisfaction. It leverages an in-house cloud computing structure, AI, and machine learning capabilities to serve its client base that is steadily growing.

Infobird trusts that its intelligent quality inspection system will help the company achieve 100% coverage and automation of intelligent quality inspection with this collaboration. It also believes that the system will allow the company to optimize the scope of quality inspection channels, customer service soft power, and speech flow, among various other aspects.

So far, Infobird’s technology and solutions for the retail and consumer product industry have been applied in various leading companies such as SaSa, a beauty brand based in Hong Kong, and Zu Li Jian, a footwear company for the elderly in China. Its solutions cover various business scenarios, including but not limited to management, marketing, and customer service. For an industry that is proliferating, Infobird has positioned itself perfectly, and this cooperation is another breakthrough in Infobird’s market development strategy in the retail and consumer product industry.

Following the pandemic, retail and consumer products introduced a historic development opportunity and sparked a growth which McKinsey & Company projects will continue, particularly in the Chinese market. In just the first half of 2021, total retail sales of consumer products in the Chinese market were over 21.2 trillion yuan, a 23% growth from the same period in 2020 and an average growth rate of 4.4% over the past two years. One central draw point from this growth is the role that digitalization of customer engagement is playing. More companies are optimizing their customer engagement process to enhance the customers’ experience through technology and business model upgrades.

Infobird understands these trends, goals, and requirements, hence its investment into the technology and services it offers. The successful client launch with this global leading retail brand demonstrates Infobird’s commitment to improving what it offers and successfully expanding into the market of retail and consumer product companies. 

For more information, visit the company’s website at www.Infobird.com/en/index.html.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD 

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Infobird Software Co. Ltd. IFBD | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Unique Set of Safety Protocols for 2021 LD Micro Main Event

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced a unique set of safety protocols for the in-person component of the 2021 LD Micro Main Event on Oct. 12-14, 2021. Marking the first in-person conference for LD Micro in almost two years, the event brings physical and virtual elements together to form a truly unique experience. LD Micro announced that several presenting companies will also be providing their product, know-how and services to the in-person Main Event to ensure that everyone is safe and comfortable during the conference. The event’s 150+ participating companies will have the option to present in-person or virtually, while all in-person presentations will also be available for online viewing. “One of the biggest perks of my job is establishing relationships with great publicly traded companies. Given the current ‘dynamic,’ I thought it would be prudent to reach out to the names that have expertise and knowledge in areas that would enhance everyone’s safety at our first in-person event in two years. Every single one is stepping up to the plate in a big way,” said Chris Lahiji, founder of LD Micro. “If the NBA can pack an indoor stadium with screaming, maskless fans, we can have an outdoor get-together. The energy is going to be unmatched because people want to see their friends again, the same goes for me as well.”

To view the full press release, visit https://ibn.fm/X8E6D

About SRAX Inc.

SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com and www.MySequire.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in SRAX, Inc. SRAX | Leave a comment

FingerMotion Inc. (FNGR) Poised to Lead a Post-Pandemic Insurance Industry Renaissance in China

  • A 2020 Deloitte China report noted that big data will be vital in ensuring insurance survive for longer post-pandemic and accelerate their transformation towards excellence 
  • Big data is instrumental in facilitating greater product innovation and pricing accuracy for insurers
  • Through its Big Data Insights division (Sapientus), FingerMotion appears well positioned as an ideal partner for insurers looking to implement Deloitte’s proposals
  • The China Banking and Insurance Regulatory Commission recently scrapped the 51% cap on foreign ownership, setting the stage for potential growth of the country’s insurance sector

Last year, Deloitte China released a report titled “COVID-19 and China’s Insurance Industry” that explored the measures insurers have taken to deal with the pandemic, the macro impact of COVID-19 on the insurance industry, and, lastly, how insurance companies should accelerate their transformation towards excellence (https://ibn.fm/U2kpn). The report noted that big data, which some insurers were already using as early as February 2020, will be instrumental in the post-pandemic insurance world. 

According to Deloitte China, the pandemic posed a significant challenge to the adaptability and resilience of insurance companies and their management teams. This means that these firms need to consider building sustainable management systems to ensure longevity moving forward. The report proposed that insurers should apply big data to facilitate product differentiation and build digital operational capabilities. 

With mechanisms already in place, having launched its Big Data Insights division (Sapientus) in July 2020 and subsequently partnered with Pacific Life Re-Insurance, evolving technology company FingerMotion (OTCQX: FNGR) appears poised as an ideal partner for insurers looking to implement Deloitte China’s proposals. 

Speaking in an August 25 corporate update, FingerMotion CEO Martin Shen noted that Sapientus stands out because of its ability to integrate publicly available data into proprietary risk matrices with behavioral indicators derived from event-driven or contextual-based information. Through the provision of behavioral analytics, FNGR is looking to supply actionable intelligence and enable efficient service delivery to potential clients within the insurance industry (https://ibn.fm/ljoZh).

Incidentally, the Deloitte report had alluded to this particular application of big data. It recommended that insurers should make full use of data from external and internal sources to “facilitate quantitative models for customer segmentation, and thus more accurate pricing and greater product innovation.”

FingerMotion’s efforts in the insurance sector coincide with a recent move by the China Banking and Insurance Regulatory Commission (“CBIRC”) to scrap the 51% cap on foreign ownership in insurance businesses in a bid to open up the domestic insurance market and expand the sector (https://ibn.fm/WJ936). 

In its analysis, Mordor Intelligence quoted the resultant potential increase in the number of insurance companies in China due to CBIRC’s move as one of the factors expected to help the sector grow even further. The market research company projects that China’s life and non-life insurance market will grow at a 6% CAGR from 2020 to 2025 (https://ibn.fm/jCqxM). At the same time, the online insurance market is expected to grow at a 41% CAGR from 2019 through 2024 (https://ibn.fm/9O90d). 

FingerMotion is a technology company with core competencies in SMS/MMS services, mobile payment and recharge solutions, and big data insights. It is also targeting the burgeoning rich communication services (“RCS”) segment, with the expectation that RCS will form the company’s fourth division once launched.

For more information, visit the company’s website at www.FingerMotion.com.

NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR 

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Healthcare Small Cap Conference

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (“OSA”), today announced that its chairman and CEO Kirk Huntsman and CFO Brad Amman will be presenting at the online Benzinga Healthcare Small Cap Conference at 2:20 pm ET on Wednesday, Sept. 29, 2021. The event is scheduled to take place from Sept. 29-30, 2021. Investors interested in joining the Vivos presentation should visit https://ibn.fm/JFY3h to register for a free spectator pass. A replay of the presentation will be available for view following the presentation on Vivos’ website.

To view the full press release, visit https://ibn.fm/XsXeO

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for adult patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”). The Vivos treatment involves customized oral appliances and treatment protocols called the Vivos System. Vivos believes that its Vivos System oral appliance technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for adults with mild-to-moderate OSA. Vivos also sells orthodontic appliances for adults and children. Vivos’ oral appliances have proven effective in over 19,000 patients treated worldwide by more than 1,250 trained dentists. Combining proprietary technologies and protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway, the Vivos System opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes VivosScore, powered by the SleepImage diagnostic technology, for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos System. For more information, visit www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Vivos Therapeutics Inc. VVOS | Leave a comment

MissionIRNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Announces AVTA Order for 28 Additional Wireless Chargers

Ideanomics (NASDAQ: IDEX), a global company focused on driving the adoption of commercial electric vehicles and associated energy consumption, and its subsidiary, WAVE, has inked a multimillion dollar purchase order from the Antelope Valley Transit Authority (“AVTA”). Acquired by IDEX earlier this year, WAVE is the leading high-power, inductive-charging solution provider for medium- and heavy-duty vehicles. The deal calls for WAVE to provide 28 additional wireless charging systems. In 2019, AVTA, which operates the largest battery-electric bus fleet in the country, became the first fully electric fleet powered by wireless charges; the company serves more than 450,000 residents in both Lancaster, California, and Palmdale, California, as well as parts of northern Los Angeles County. “AVTA has been a strong supporter and customer of WAVE for years, and with this order, they are doubling down on their commitment to provide green, sustainable public transportation for the people of California,” said WAVE CEO Aaron Gillmore in the pess release. “AVTA is setting a great example for how other cities can create real change in their mass transit systems, and as this movement spreads throughout the U.S., WAVE will be ready to jump in and partner with other agencies to eliminate any concerns they may have with range limits when converting to electric fleets.”

To view the full press release, visit https://ibn.fm/vKt3k

About Ideanomics Inc.

Ideanomics is a global company focused on the convergence of financial services and industries experiencing technological disruption. The Ideanomics Mobility division is a service provider that facilitates the adoption of electric vehicles by commercial fleet operators through offering vehicle procurement, finance and leasing, and energy-management solutions under the company’s innovative sales-to-financing-to-charging (“S2F2C”) business model. Ideanomics Capital is focused on disruptive fintech solutions for the financial services industry. Together, Ideanomics Mobility and Ideanomics Capital provide the company’s global customers and partners with leading technologies and services designed to improve transparency, efficiency and accountability, and the company’s shareholders with the opportunity to participate in high-potential, growth industries. For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Ideanomics IDEX, | Leave a comment

Flora Growth Corp. (NASDAQ: FLGC) Makes Early Leap into Expected Opening of Cannabis Trade in Panama

  • Flora Growth Corp., a cannabis company with low-cost cultivation and global distribution, recently reached a non-binding LOI with Panamanian importer and distributor Robust Farms Inc. to supply product from its portfolio  
  • Panama is a country on the verge of opening to medical marijuana sales and the first in Central America to open a regulated market following legislation approved without a dissenting vote by the National Assembly
  • Flora Growth maintains a large licensed outdoor operation in Colombia, from which it cultivates cannabis that will be used in a variety of branded products 
  • Flora Growth has been increasing its international outlets, including an agreement with Hoshi International Inc. expected to open up numerous opportunities in the European Union 

On the heels of news that Panama’s National Assembly congress passed legislation legalizing medical marijuana (https://ibn.fm/gfh8W), internationally focused cannabis cultivator and brand builder Flora Growth (NASDAQ: FLGC) is generating excitement through the establishment of a non-binding LOI with Panamanian importer and distributor Robust Farms Inc. to supply its premium cannabidiol (“CBD”)-derivative products. 

Panamanian President Laurentino Cortizo is expected to sign the legislation despite a veto campaign from the conservative political opposition, which will make Panama the first Central American nation to regulate the leafy green plant following decades of drug war rhetoric against cannabis and its marijuana product (https://ibn.fm/QOueo).

Flora Growth will provide Panama’s Robust Farms with cannabinoid-containing food and beverages through its Kasa Wholefoods division, according to the company, once Robust’s cannabis import licensed is approved.

Flora will also provide finished medical-grade cannabis products for patients under the expected regulatory framework.

“We’re extremely pleased to enter into this agreement with Flora in order to pre-emptively secure access to their medical-grade cannabis products — which we believe is the first of its kind to be announced since the cannabis legislation passed — and look forward to supplying our clients with Flora’s premium portfolio of CBD-infused and non-CBD food and beverage products in the short term,” Robust CEO Maurice Holmes Mendez stated in the news release about the LOI (https://ibn.fm/OALh6).

“While the new proposed framework awaits signature from the President, our team is hard at work building out our traditional and medical cannabis sales channels in the LATAM region, which relies heavily on working with experienced business partners and healthcare practitioners,” Mendez added. 

Flora Growth is headquartered in Canada, with its sights on relocating offices to the United States and core product cultivation operations in Colombia. The company’s end user markets include Australia and various countries in Latin America, Europe and Asia, demonstrating its global reach.

The company’s European expansion plans are being advanced through the recent closure of a €2 million investment in Hoshi International Inc. — a fully integrated cannabis company with strong experience in working in the European market (https://ibn.fm/p7az0).

Germany, which leads the European cannabis market in terms of growth, completed an estimated €111 million in medical cannabis trade between January and September of last year, with flower sales making up about 48.6 percent of the market, according to the Hoshi investment announcement. 

For more information, visit the company’s website at www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Flora Growth Corp. FLGC | Leave a comment

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receives College of American Pathologists Accreditation for U.S. Laboratory

  • AnPac Bio’s clinical laboratories are located in the U.S. and China, with a total of 142 patents issued as of March 2021
  • Cancer Differentiation Analysis (“CDA”) technology is AnPac Bio’s approach to early cancer detection and screening technology, with over 200,000 samples and cases to serve as a way of approaching cancer screening
  • Company’s ownership percentage in subsidiary AnPai (Shanghai) Healthcare Management Consultant Co. Ltd. has increased from 20% to 60%, following rigorous regulatory assessments and audits

With a focus on early cancer screening and detection, biotechnology company AnPac Bio-Medical Science (NASDAQ: ANPC) recently announced that its U.S. laboratory has received accreditation from the College of American Pathologists (“CAP”). The U.S. federal government recognizes the CAP Laboratory Accreditation Program as equivalent to or more stringent than the government’s inspection program for laboratories. The accreditation from CAP is considered the gold standard for laboratories of this nature (https://ibn.fm/05KFN). 

AnPac Bio has clinical laboratories in the U.S. and China, totaling 142 patents issued as of March 2021. The company’s approach for detecting cancer and precancerous diseases is called Cancer Differentiation Analysis (“CDA”) and uses biophysical properties found in the blood to discover changing micro-environments towards cancerous micro-environments before the tumors are even formed.  CDA technology uses an assessment of biophysical properties in the blood, and CDA platform combines CDA technology with other tests such as biomarkers.  CDA is also helpful in potentially predicting multiple cancer types, through a blood test, which is a highly competitive price point.

AnPac Bio’s CDA is powered by a database completed with over 200,000 samples and cases to serve as a new way of approaching disease and cancer screening. The company is an early thought leader and developer of multi-cancer ideas and technology, having begun its patent applications and IP in 2010, with the initial cancer detection test offering being able to detect 16 types of cancer announced by 2014.

In addition to its CAP accreditation in the U.S., AnPac Bio has increased its ownership percentage in subsidiary AnPai (Shanghai) Healthcare Management Consultant Co., Ltd., as approved by the audit committee and board of directors. The ownership increase from 20% to 60% follows a required due diligence process of financial and legal audits, in addition to appraisals by a qualified appraiser (https://ibn.fm/ZDDAY).

“AnPac Bio is excited to have completed this important step. We are able to successfully incorporate with AnPai’s wide diversity of customers and high revenue growth through this transaction,” Dr. Chris Yu, CEO and Chairman of AnPac Bio said, commenting on the ownership share acquisition. “In the future, we will achieve faster and greater progress and development in the diversity of customers and the professionalism of our services, as well as projected sustainable revenue growth through our greater share ownership. We hope that customers will benefit from AnPac Bio’s CDA technology.”

AnPac Bio’s CDA technology addresses numerous goals, which include innovating the cancer screening industry, detecting early signs of cancer in the body, identifying up to 26 different types of cancers, providing multi-level/multi-parameter analysis, proving the efficacy of the CDA technology through the 200,000 samples, and using human blood for the means of identifying biophysical properties in conjunction with cancer occurrences. 

The technology has positioned AnPac Bio as a leader on the cancer detection and screening market, with the largest on-going multi-cancer follow-up study in the world, an expanding market expected to reach $249.6 billion by 2026, growing at a CAGR of 7% during the forecast period. The rising incidence of cancer is triggering a higher demand for available and effective screenings and testing necessary for monitoring disease progression and increasing preventative measures.

For more information, visit the company’s website at www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC 

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in AnPac Bio-Medical Science Co. Ltd. ANPC | Leave a comment

Tingo Inc. (IWBB) Joins the Billion Dollar Club – Twice

Not often does a company gain entry to the billion-dollar club. However, technology and communications pioneer Tingo (OTCQB: IWBB) just did it – twice.  Shortly after going public in a deal valued at $3.7 billion, Tingo rang the billion-dollar bell a second time with its acceptance into IBN’s Billion Dollar Club. This powerful adjunct program created exclusively for IBN CORE Client Partners gives Tingo personal access to Oren Klaff, best-selling author and world-renowned expert on sales, revenue acceleration and high-stakes negotiations. 

Commenting on the recent billion-dollar bonanza, Dozy Mmobuosi, CEO and co-founder of Tingo, stated, “Going public is the next stage in our overarching strategy to build complete digital ecosystems that promote financial inclusion, deliver disruptive financial services, and expand international economic opportunities across the entire continent of Africa. With our proven success in Nigeria, we are already well on our way to becoming the continent’s leading Agri-Fintech player. Going public provides us greater global recognition and access to capital markets which will help expedite our process to becoming a driving force in the economic expansion of the continent. We chose IBN for Tingo’s corporate communications needs based on their history of successfully serving over 500 public companies and their unwavering commitment to clearly communicating our message and helping us achieve our objectives. We were thrilled to discover that we also could get exclusive access to Oren Klaff and his expertise as part of our services and fully expect to rapidly accelerate our revenues and growth with his guidance and tutelage.”

Tingo has been on a 20-year journey to billion-dollar status. Mmobuosi created Tingo in 2001 with a vision to build an ecosystem to support the largely unbanked agricultural sector in Nigeria. Tingo designed first SMS mobile banking and payment platform in Nigeria which is still in use today. With hard work and vision, Tingo has evolved into a rapidly expanding group of Fintech, Agritech, mobile, technology companies. Tingo provides strategic direction and corporate support to its subsidiaries, which offer telecommunications services, smartphones, voice & data services (its Tingo Mobile PLC subsidiary has sold over 21 million mobile devices over the past 7 years) and Agritech solutions, enabling access to global commodities markets, extension services and fintech tools for millions of small farmers.  

With over $600 million in annual revenues and nearly 10 million subscribers, Tingo is Nigeria’s leading Agri-Fintech and device-as-a-service company. Tingo helps farmers acquire mobile phones through a unique leasing plan and connects them to mobile and data networks through its own virtual mobile network. Tingo’s digital platform provides market access for farmers and cooperatives to sell their produce at either wholesale or retail levels, achieving the best possible market price, and currently processes over 500,000 transactions a day. 

Tingo continues to innovate and expand services across the continent, recently launching a beta version of TingoPay, a B2B and B2C Fintech app that will provide financial services to users inside and outside of agriculture offering mobile wallets, payment processing and access to specialist lenders, insurers and pension products. Tingo also plans to roll out a blockchain-based solution that will deliver frictionless trade across borders in Africa. The company’s successful market-proven model gives Tingo the unique ability to deliver the same service model across all of Africa and transform the continent with its innovative fintech and agriculture value chain solutions powered through smartphone technology.

For more information, visit the company’s website at www.TingoGroup.com

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/IWBB

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Tingo Inc. IWBB | Leave a comment

MissionIRNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Technologies Inc. Announce Definitive Agreement for Class 1 and 2 EV Cargo Vans for Assembly, Sales in US and Mexico

Mullen Technologies, an emerging electric vehicle manufacturer, which previously announced a definitive agreement to merge with Net Element (NASDAQ: NETE), today announced its entry into a definitive agreement with Tenglong Automotive, a subsidiary of CRRC Group, for manufacturing, distribution and retail sales of Class 1 and Class 2 EV Cargo Vans in the U.S. and Mexico. According to the update, the agreement provides Mullen with an effective solution for the fast-developing EV cargo van market and its existing EV fleet van orders. Mullen will homologate and assemble the vans at its Tunica, Mississippi- based Advanced Manufacturing and Engineering Facility (“AMEC”). “EV Cargo Vans are a natural segment for us and is a perfect fit for our Tunica AMEC facility,” said David Michery, CEO and chairman of Mullen. “This is also a win-win for us and our investors. We can begin to fulfill existing fleet orders in the first quarter of 2022, which will generate revenue and begin our manufacturing process in Tunica, Mississippi. We expect to hire a significant number of Americans for start of production at our AMEC facility.”

To view the full news release, visit https://ibn.fm/uK1jk

About Net Element Inc.

Net Element operates a payments-as-a-service transactional and value-added services platform for small and medium enterprises (“SMEs”) in the U.S. and selected emerging markets. In the U.S., the company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, its cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500(TM). In 2017, it was recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. For additional information, visit www.NetElement.com.

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Net Element Inc. NETE | Leave a comment